Zofran Lawsuit and Recall

Zofran is an anti-nausea drug that’s used “off-label” for morning illness, connected with a 30% greater chance of birth defects along with a double chance of heart defects and cleft palate, based on several recent lawsuit reports. Zofran was manufactured by GlaxoSmithKline (GSK) and approved within the in 1991 in the United States. The very first generic versions were approved in the year 2006.

In recent year, Zofran lawyers are trying hard to look for the connection between Zofran taken for morning illness during the entire initial trimester of being pregnant and heavy fetal injuries including cleft lip, cleft palate and hereditary heart defects. We know there are now solid evidences that Zofran (ondansetron) might be the reason for these defects.

The Food and drug administration never approved this drug for morning illness and GlaxoSmithKline (GSK), the manufacturer of the drug, compensated a $2 billion settlement in the civil suit that involved accusations that GSK unlawfully marketed its Zofran drug to become recommended to expectant moms. This settlement didn’t include obligations for injuries experienced because of using Zofran. Your child and you might be legally titled to compensation for pain and suffering, medical costs, lack of earnings, emotional hardship along with other damages.

Zofran Lawsuits

Doctors recommend Zofran (ondansetron) to women that are pregnant as their treatment of vomiting and nausea throughout pregnancy. Regrettably, studies found this medicine leads to birth defects, and people are taking drug manufacturer GlaxoSmithKline to the court, saying it promoted the drug to women that are pregnant without Food and drug administration approval.

  • Birth defects
  • Heart defects
  • Heart murmur
  • Atrial septal defect
  • Ventricular septal defect
  • Hole within the heart
  • Cleft lip
  • Cleft palate
  • Bone and joint Defects
  • Fetal growth restriction
  • Kidney defects
  • Hydronephrosis
  • Hypospadia
  • And many more other injuries.

Zofran Recall

The Food and drug administration has recalled Zofran in 32-mg intravenous doses as a result of worrying about the abnormal heart beat and disorders, including QT interval prolongation and Torsades p Pointes.

In December 2012, recall was introduced for 32-mg intravenous (IV) Zofran and also the U.S. Fda (Food and drug administration) has released more alerts about the chance of severe, existence-threatening heart rhythm disorders.

The Food and drug administration continues to be looking into the connection between Zofran and heart disease since September 2011. They inquired the manufacturer of Zofran, GlaxoSmithKline (GSK), to conduct new safety studies.


Stay Updated With Us

Check out our current updates including Zofran, the present lawsuit about the drug and also the new remedies and clinical tests happening.

We Offer Qualified Lawyer

If you think maybe there is a legal situation from the makers of Zofran, we are able to support you. We’ll enable you to get use of a professional Birth Injuries Lawyer, who is able to guide to you through the entire lawsuit process.

Legal Rights

It is your legal right to get the compensation by filing a lawsuit if you your child or known relatives have faced any side effects of Zofran or the birth injuries. So you contact our lawyers immediately for a free case consultation